Comment on CMS-2026-1255-0001

Summary: The Blue Cross Blue Shield Association (BCBSA) supports the proposed rule to expand electronic prior authorization (ePA) to prescription drugs but requests several technical modifications. They specifically advocate for extending implementation deadlines by two years, establishing clear versioning guardrails for FHIR standards, and ensuring that reporting metrics remain percentage-based rather than including raw counts to maintain comparability across payers.